Proclin Research Surpasses 150 Completed Clinical Trials

Proclin Research today announced it has completed more than 150 clinical trials across a broad range of therapeutic areas. The milestone underscores the organization's commitment to ethical conduct, data integrity and accelerating access to new medicine.

With a network of 350+ clinical trial sites across India — including formal agreements at more than 70 — Proclin partners with clinical-stage sponsors from the U.S., Israel, Singapore and Europe on cost-effective, innovation-forward studies.

The company reaffirmed its focus on ophthalmology, medical devices, IVDs, nutraceuticals and public health — supported by in-house risk-based analytics and a cloud-based site management platform.